Answers are grounded in this paper and cite their sources.
At 24 weeks, a single course of rituximab with concomitant MTX therapy provided significant and clinically meaningful improvements in disease activity in patients with active, longstanding RA who had an inadequate response to 1 or more anti-TNF therapies.
No takes yet. Share an insight, caveat, or question.
Cohen et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: